Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by NewMediaWire

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
HUMACYTE DEADLINE: Investors Are Encouraged to Contact Kaplan Fox Before the Lead Plaintiff Deadline on January 17, 2025
Via NewMediaWire
HUMA Deadline to Lead in Securities Fraud Lawsuit is January 17, 2025 - Contact Kaplan Fox & Kilsheimer LLP
Via NewMediaWire
Topics Fraud Lawsuit
Exposures Financial Legal
Women Warriors: A Legacy in Martial Arts
Via NewMediaWire
Deadline to Lead in Securities Fraud Lawsuit Against Humacyte, Inc. (HUMA) is January 17, 2025 - Contact Kaplan Fox & Kilsheimer LLP
Via NewMediaWire
Topics Fraud Lawsuit
Exposures Financial Legal
Kaplan Fox & Kilsheimer LLP Alerts Investors to a Securities Class Action Against Humacyte, Inc. (HUMA) - Deadline is January 17, 2025
Via NewMediaWire
In a small international trial, novel oral medication muvalaplin lowered Lp(a)
Via NewMediaWire
Nasal spray version of common diuretic has potential to help treat heart failure
Via NewMediaWire
NFL s Arizona Cardinals provide 12 schools with CPR resources to improve cardiac emergency outcomes
Via NewMediaWire
Lost in the Labyrinth of L.A.'s Quirky Museums
Via NewMediaWire
NFL s Colts bring CPR education to flag football to improve cardiac emergency outcomes
Via NewMediaWire
NY AI medical company wins global health tech competition at Scientific Sessions 2024
Via NewMediaWire
Topics Artificial Intelligence
Exposures Artificial Intelligence
Lifestyle & risk factor changes improved AFib symptoms, not burden, over standard care
Via NewMediaWire
QTRX ALERT: Kaplan Fox & Kilsheimer LLP is Investigating Quanterix Corp (QTRX) for Potential Securities Law Violations
Via NewMediaWire
A common heart failure medication may help prevent heart damage related to chemotherapy
Via NewMediaWire
Reconditioned pacemakers worked as well as new ones
Via NewMediaWire
Email reminders improved flu shot rates in Denmark, notably among heart attack survivors
Via NewMediaWire
Two-medication combo pill lowered blood pressure among adults in India
Via NewMediaWire
Spironolactone, a blood pressure medication, may help reduce risk of new heart failure
Via NewMediaWire
Topics Death
Exposures Death
Patients taking edoxoban after heart valve surgery had lower risk of stroke, blood clots
Via NewMediaWire
Exenatide, a GLP-1 analog, by IV during cardiac surgery did not reduce organ injury or death
Via NewMediaWire
AI image-recognition program could read heart images faster, speed care
Via NewMediaWire
Topics Artificial Intelligence
Exposures Artificial Intelligence
Giving pharmacists feedback improved care for veterans with heart failure
Via NewMediaWire
Blood thinners didn t reduce cognitive decline in adults 65 and younger with AFib
Via NewMediaWire
Ablation may be better than medication for those with dangerous heartbeat after heart attack
Via NewMediaWire
Tirzepatide lowered risk of worsening heart failure and CVD death for obese adults
Via NewMediaWire
Systolic BP of less than 120 mm Hg reduced CVD risk in adults with Type 2 diabetes
Via NewMediaWire
FRANKLIN RESOURCES IS THE TARGET OF MULTIPLE GOVERNMENT INVESTIGATIONS - Contact Kaplan Fox & Kilsheimer LLP
Via NewMediaWire
Tickers BEN
Quanterix Investors are Encouraged to Contact Kaplan Fox & Kilsheimer LLP Regarding Potential Securities Law Violations
Via NewMediaWire
Elanco (ELAN) Hit With Investor Lawsuit Over New Drug - Hagens Berman
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
Tickers ELAN
PACS Group (PACS) Faces Securities Class Action - Hagens Berman
Via NewMediaWire
Topics Initial Public Offering
Exposures Securities Market
Tickers PACS
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.